RelieVRx (Pico G3)
Appliedvr · K251519
FDA-authorized Predetermined Change Control Plan
- Company
- Appliedvr
- 510(k)/De Novo #
- K251519
- Decision date
- 2025-08-13
- Panel
- Neurology
- Pathway
- 510(k)
- Category
- Non-AI
- PCCP type
- Hardware
- Monitoring commitment
- Not stated
What this PCCP covers. Permits hardware configuration changes
Other Neurology PCCPs
- K260582ROSA® Shoulder SystemOrthosoft Inc. (d/b/a) Zimmer CAS2026-05-21AI hardwareCompatibility expansion
- K252842SafeOp 3: Neural Informatix SystemAlphatec Spine, Inc.2026-01-11AI hardwareRetraining
- K251936Ceribell Delirium Monitor SystemCeribell, Inc.2025-12-08AI/SaMDRetraining
- K252070Ceribell Infant Seizure Detection SoftwareCeribell, Inc.2025-11-21AI/SaMDRetraining
- K243558Canvas DxCognoa, Inc.2025-04-11AI/SaMDRetraining
- K241589Ceribell Seizure Detection SoftwareCeribell, Inc.2025-04-09AI/SaMDRetraining
Want the monitoring teardown?
We read the PCCP for RelieVRx (Pico G3), then map the post-market monitoring that its modification protocol requires, including the deployment-period evidence most teams can't reconstruct at modification time. Sentir is the independent system of record that produces it.
Book a callSource: U.S. FDA public records (openFDA 510(k)/De Novo databases and accessdata.fda.gov). PCCP type and category are editorial classifications based on public documents, not official FDA designations.
This page is a factual summary of public FDA records. Sentir Health is not affiliated with or endorsed by the named companies or the U.S. Food and Drug Administration. Spot an error? Request a correction.